- Home
- EVOK vs CHNR Comparison
EVOK vs CHNR Comparison
Compare EVOK & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- CHNR
- Stock Information
- Founded
- EVOK 2007
- CHNR N/A
- Country
- EVOK United States
- CHNR Hong Kong
- Employees
- EVOK N/A
- CHNR N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- EVOK Health Care
- CHNR Basic Materials
- Exchange
- EVOK Nasdaq
- CHNR Nasdaq
- Market Cap
- EVOK 6.5M
- CHNR 6.1M
- IPO Year
- EVOK 2013
- CHNR 1995
- Fundamental
- Price
- EVOK $4.47
- CHNR $0.59
- Analyst Decision
- EVOK
- CHNR
- Analyst Count
- EVOK 0
- CHNR 0
- Target Price
- EVOK N/A
- CHNR N/A
- AVG Volume (30 Days)
- EVOK 29.5K
- CHNR 392.2K
- Earning Date
- EVOK 03-13-2025
- CHNR 01-01-0001
- Dividend Yield
- EVOK N/A
- CHNR N/A
- EPS Growth
- EVOK N/A
- CHNR N/A
- EPS
- EVOK N/A
- CHNR N/A
- Revenue
- EVOK $8,617,036.00
- CHNR N/A
- Revenue This Year
- EVOK $97.35
- CHNR N/A
- Revenue Next Year
- EVOK $99.52
- CHNR N/A
- P/E Ratio
- EVOK N/A
- CHNR N/A
- Revenue Growth
- EVOK 100.35
- CHNR N/A
- 52 Week Low
- EVOK $3.54
- CHNR $0.51
- 52 Week High
- EVOK $12.32
- CHNR $8.85
- Technical
- Relative Strength Index (RSI)
- EVOK 47.52
- CHNR 46.77
- Support Level
- EVOK $4.30
- CHNR $0.62
- Resistance Level
- EVOK $4.58
- CHNR $0.64
- Average True Range (ATR)
- EVOK 0.26
- CHNR 0.06
- MACD
- EVOK -0.00
- CHNR -0.00
- Stochastic Oscillator
- EVOK 48.22
- CHNR 15.09
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.